GGrantIndex
← Leaderboards

Heather Taffet Gold

New York University School Of Medicine

$3,209,058
Attributed
$6,239,315
Total exposure
6
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY201125
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

CDC$4,249,911 · 2
NIH$1,660,479 · 2
AHRQ$328,925 · 2

By mechanism

U01$3,649,997 · 1
R01$1,435,022 · 1
U48$599,914 · 1
R21$293,981 · 1
R03$225,457 · 1
R13$34,944 · 1

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Woman

Research focus

WomanMalignant Breast NeoplasmVariantMorbidity - Disease RateBreast Cancer TreatmentGuidelinesMedicarePhysiciansOutpatientsBreastAdjuvant ChemotherapyBreast Cancer PatientBreast Cancer DiagnosisBreast-Conserving SurgeryAffectAccountingChronicChemotherapyCathetersBrachytherapyAdverse EffectsClinical DataClinical TrialsCaring

Grant awards (16)

DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health$899,999
U01 · FY2025 · DP
Economic Evaluation of MEW Network Epilepsy Self-Management Programs$299,957
U48 · FY2025 · DP
DP22-002 HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health$950,000
U01 · FY2024 · DP
Economic Evaluation of MEW Network Epilepsy Self-Management Programs$299,957
U48 · FY2024 · DP
HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health$899,999
U01 · FY2023 · DP
HEALTH: Harnessing Epidemiology to Advance Lupus Treatment and Health$899,999
U01 · FY2022 · DP
Development and evaluation of patient-reported outcome score visualization to improve their utilization (PROVIZ)$143,700
R21 · FY2020 · HS · contact PI
Development and evaluation of patient-reported outcome score visualization to improve their utilization (PROVIZ)$150,281
R21 · FY2019 · HS · contact PI
Treatment and Outcomes in Diabetic Breast Cancer Patients$186,527
R01 · FY2018 · CA · contact PI
Treatment and Outcomes in Diabetic Breast Cancer Patients$406,860
R01 · FY2017 · CA · contact PI
Treatment and Outcomes in Diabetic Breast Cancer Patients$416,802
R01 · FY2016 · CA · contact PI
Treatment and Outcomes in Diabetic Breast Cancer Patients$424,833
R01 · FY2015 · CA · contact PI
Costs and Complications of Radiotherapy Modalities$56,457
R03 · FY2014 · CA · contact PI
Reflecting AHRQ Missions through Innovative Programming at SMDM Annual Meeting$34,944
R13 · FY2013 · HS · contact PI
Costs and Complications of Radiotherapy Modalities$84,500
R03 · FY2012 · CA · contact PI
Costs and Complications of Radiotherapy Modalities$84,500
R03 · FY2011 · CA · contact PI